5Norton C,Georgiopoulou VV,Kalogeropoulos AP. Epidemiology and cost of advanced heart failure[J].{H}Progress in Cardiovascular Diseases,2011,(02):78-85. 被引量：1
6Bui AL,Horwich TB,Fonarow GC. Epidemiology and risk profile of heart failure[J].Nat Rev Cardiol,2011,(01):30-41. 被引量：1
9Flessas N,Alexanian I,Parissis J,et al.Plasma activity of B-type natriuretic peptide in patients with biventricular heart failure versus those with right heart failure due to chronic obstructive pulmonary disease[J].J Cardiovasc Med(Hagerstown),2014(6):476-480. 被引量：1
10Bonderman D,Pretsch I,Steringer-Mascherbauer R,et al.Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure(DILATE-1):A randomized,Double-Blind,Placebo-Controlled,Single-Dose Study[J].Chest,2014(5):856. 被引量：1
